UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000026652
Receipt number R000030571
Scientific Title The Efficacy of ultrasound-guided pudendal nerve block for prevention of postoperative Catheter-Related Bladder Discomfort in patients undergoing transurethral resection of bladder tumor
Date of disclosure of the study information 2017/04/01
Last modified on 2018/03/30 08:33:23

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The Efficacy of ultrasound-guided pudendal nerve block for prevention of postoperative Catheter-Related Bladder Discomfort in patients undergoing transurethral resection of bladder tumor

Acronym

The Efficacy of ultrasound-guided pudendal nerve block for prevention of postoperative Catheter-Related Bladder Discomfort in patients undergoing transurethral resection of bladder tumor

Scientific Title

The Efficacy of ultrasound-guided pudendal nerve block for prevention of postoperative Catheter-Related Bladder Discomfort in patients undergoing transurethral resection of bladder tumor

Scientific Title:Acronym

The Efficacy of ultrasound-guided pudendal nerve block for prevention of postoperative Catheter-Related Bladder Discomfort in patients undergoing transurethral resection of bladder tumor

Region

Japan


Condition

Condition

Transurethral resection of bladder tumor

Classification by specialty

Urology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to evaluate the efficacy of ultrasound-guided pudendal nerve block for prevention of postoperative CRBD in patients undergoing transurethral resection of bladder tumor.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The incidence of CRBD at 0, 1, 2, 6 and 24h after surgery.

Key secondary outcomes

The severity of CRBD at 0,1,2,6,24h after surgery
(0=no CRBD,1=mild,2=moderate,3=severe)

NRS at 0,1,2,6,24h after surgery

The severity of sciatic nerve block at 0,1,2,6,24h after surgery
(tibial nerve,peroneal nerve)
sensory(0=no block,1=analgasia,2=anesthesia)
motor(0=no block,1=paresis,2=paralysis)

Analgesic consumption at 24h after surgery


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Cluster

Blinding

Double blind -all involved are blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Prevention

Type of intervention

Medicine Device,equipment Maneuver

Interventions/Control_1

Pudendal nerve block is performed at the end of surgery.

In pudendal nerve block group 10ml levobupivacaine0.375% is injected in each side for total 20ml.

Interventions/Control_2

caudal anesthesia is performed at the end of surgery.

In caudal anesthsia group 20ml of levobupivacaine0.375% is injected.

Interventions/Control_3

Peripheral nerve block is not performed in the control group.

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

90 years-old >=

Gender

Male

Key inclusion criteria

ASA physical status1-3
Patients scheduled for elective transurethral resection of bladder tumor

Key exclusion criteria

bladder outflow obstruction,overactive bladder(which is defined as urinary frequency more than three times in the night or more than eight times in 24 h),end-stage renal disease(serum creatinine>1.6mg/dl),neurogenic bladder,morbid obesity,use of chronic analgesic medication,use of muscarinic receptor antagonists,psychiatirc disease,allergy of local anesthetics,peripheral neuropathy

Target sample size

150


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yuki Izumi

Organization

Asahikawa Medical University

Division name

Department of Anesthesiology&Critical care

Zip code


Address

Midorigaoka-higashi 2-1-1-1, Asahikawa, Hokkaido 078-8510, Japan

TEL

0166682583

Email

yuki0811izumi@yahoo.co.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yuki Izumi

Organization

Asahikawa Medical University

Division name

Department of Anesthesiology&Critical care

Zip code


Address

Midorigaoka-higashi 2-1-1-1, Asahikawa, Hokkaido 078-8510, Japan

TEL

0166682583

Homepage URL


Email

yuki0811izumi@yahoo.co.jp


Sponsor or person

Institute

Asahikawa Medical University

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2017 Year 02 Month 01 Day

Date of IRB


Anticipated trial start date

2017 Year 04 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 03 Month 22 Day

Last modified on

2018 Year 03 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030571